We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$880B
AUM Growth
+$147B
Cap. Flow
+$97B
Cap. Flow %
11.02%
Top 10 Hldgs %
14.5%
Holding
8,205
New
199
Increased
3,814
Reduced
2,948
Closed
311

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.71B
2
MSFT icon
Microsoft
MSFT
+$3.52B
3
AMZN icon
Amazon
AMZN
+$2.04B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.87B
5
LLY icon
Eli Lilly
LLY
+$1.31B

Sector Composition

Rank Sector Weight
1 Technology 17.3%
2 Healthcare 12.11%
3 Financials 10.63%
4 Consumer Discretionary 8.09%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNZIW
7351
DELISTED
Banzai International Warrant
BNZIW
$255 ﹤0.01%
3,646
GENI.WS
7352
DELISTED
Genius Sports Limited Redeemable Warrants, each whole warrant exercisable for one Ordinary Share each at an exercise price of $11. 50 per share
GENI.WS
$254 ﹤0.01%
283
DRTT
7353
DELISTED
DIRTT Environmental Solutions Ltd. Common Shares
DRTT
$253 ﹤0.01%
477
-766
-62% -$277
NH
7354
DELISTED
NantHealth, Inc
NH
$248 ﹤0.01%
68
-509
-88% -$2.16K
SER icon
7355
Serina Therapeutics
SER
$41.7M
$245 ﹤0.01%
13
+4
+44% +$84
KMLM icon
7356
KFA Mount Lucas Managed Futures Index Strategy ETF
KMLM
$414M
$244 ﹤0.01%
+8
New +$287
SFBC
7357
Sound Financial Bancorp
SFBC
$111M
$236 ﹤0.01%
+6
New +$241
VYNT
7358
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$234 ﹤0.01%
333
-3,677
-92% -$5.98K
DRMA icon
7359
Dermata Therapeutics
DRMA
$4.34M
0
AIU
7360
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
$230 ﹤0.01%
44
-76
-63% -$408
SRAX
7361
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$230 ﹤0.01%
150
-310
-67% -$499
MTCR
7362
DELISTED
Metacrine, Inc. Common Stock
MTCR
$224 ﹤0.01%
500
TGL icon
7363
Treasure Global
TGL
$5.98M
0
PAVMZ
7364
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$220 ﹤0.01%
1,000
LMDXW
7365
DELISTED
LumiraDx Limited Warrant
LMDXW
$220 ﹤0.01%
3,727
-179,664
-98% -$24.5K
CANO.WS
7366
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$220 ﹤0.01%
1,000
ISPOW
7367
DELISTED
Inspirato Inc Warrant
ISPOW
$219 ﹤0.01%
2,489
CPTNW
7368
DELISTED
Cepton, Inc. Warrant
CPTNW
$219 ﹤0.01%
2,576
KRBP
7369
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$218 ﹤0.01%
40
LEV.WS
7370
DELISTED
The Lion Electric Company Redeemable Warrants, each whole warrant entitles the holder to purchase one Common Share at a price of $11.50 per share
LEV.WS
$214 ﹤0.01%
479
ENSC icon
7371
Ensysce Biosciences
ENSC
$6.46M
$207 ﹤0.01%
+2
New +$950
KAVL
7372
DELISTED
Kaival Brands Innovations Group
KAVL
$206 ﹤0.01%
11
-38
-78% -$841
XTNT icon
7373
Xtant Medical Holdings
XTNT
$44.9M
$205 ﹤0.01%
311
+281
+937% +$184
NEXI
7374
DELISTED
NexImmune, Inc. Common Stock
NEXI
$199 ﹤0.01%
33
-104
-76% -$1.3K
KXIN icon
7375
Kaixin Holdings
KXIN
$8.43M
0

Similar funds

Morgan Stanley's Q4 2022 Portfolio in Review

As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.

  • Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
  • Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
  • Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
  • Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
  • Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
  • Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
  • Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.